Last reviewed · How we verify
Female Facial Hirsutism
Approved treatments
- L-Ornithine
- Vaniqa
Eflornithine inhibits ornithine decarboxylase, reducing polyamine synthesis and affecting cancer cell growth and metabolism.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Female Facial Hirsutism patent landscape — cliff calendar, originator estates, attackable patents
- Female Facial Hirsutism treatment landscape brief
- Female Facial Hirsutism treatment updates RSS
Frequently asked questions about Female Facial Hirsutism
What drugs treat Female Facial Hirsutism?
Tracked treatments include L-Ornithine, Vaniqa.
What is the treatment for Female Facial Hirsutism?
Standard treatment for Female Facial Hirsutism includes L-Ornithine, Vaniqa. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Female Facial Hirsutism patent cliff · Female Facial Hirsutism CI report
- Treatment: L-Ornithine
- Treatment: Vaniqa
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing